BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 12136059)

  • 1. Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency.
    Takanashi J; Kurihara A; Tomita M; Kanazawa M; Yamamoto S; Morita F; Ikehira H; Tanada S; Kohno Y
    Neurology; 2002 Jul; 59(2):210-4. PubMed ID: 12136059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1H MRS identifies symptomatic and asymptomatic subjects with partial ornithine transcarbamylase deficiency.
    Gropman AL; Fricke ST; Seltzer RR; Hailu A; Adeyemo A; Sawyer A; van Meter J; Gaillard WD; McCarter R; Tuchman M; Batshaw M;
    Mol Genet Metab; 2008; 95(1-2):21-30. PubMed ID: 18662894
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1H MRS allows brain phenotype differentiation in sisters with late onset ornithine transcarbamylase deficiency (OTCD) and discordant clinical presentations.
    Gropman AL; Seltzer RR; Yudkoff M; Sawyer A; VanMeter J; Fricke ST
    Mol Genet Metab; 2008 May; 94(1):52-60. PubMed ID: 18262815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Valproate-induced metabolic changes in patients with epilepsy: assessment with H-MRS.
    Garcia M; Huppertz HJ; Ziyeh S; Buechert M; Schumacher M; Mader I
    Epilepsia; 2009 Mar; 50(3):486-92. PubMed ID: 19183221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ornithine transcarbamylase deficiency with persistent abnormality in cerebral glutamate metabolism in adults.
    Gropman AL; Sailasuta N; Harris KC; Abulseoud O; Ross BD
    Radiology; 2009 Sep; 252(3):833-41. PubMed ID: 19567648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral diffusion tensor imaging and in vivo proton magnetic resonance spectroscopy in patients with fulminant hepatic failure.
    Saksena S; Rai V; Saraswat VA; Rathore RS; Purwar A; Kumar M; Thomas MA; Gupta RK
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 2):e111-9. PubMed ID: 17924951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of enzyme activity assay on indication in liver transplantation for ornithine transcarbamylase deficiency.
    Wakiya T; Sanada Y; Urahashi T; Ihara Y; Yamada N; Okada N; Ushijima K; Otomo S; Sakamoto K; Murayama K; Takayanagi M; Hakamada K; Yasuda Y; Mizuta K
    Mol Genet Metab; 2012 Mar; 105(3):404-7. PubMed ID: 22264779
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo 1H magnetic resonance spectroscopy-derived metabolite variations between acute-on-chronic liver failure and acute liver failure.
    Verma A; Saraswat VA; Radha Krishna Y; Nath K; Thomas MA; Gupta RK
    Liver Int; 2008 Sep; 28(8):1095-103. PubMed ID: 18266634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative proton MRS of Pelizaeus-Merzbacher disease: evidence of dys- and hypomyelination.
    Hanefeld FA; Brockmann K; Pouwels PJ; Wilken B; Frahm J; Dechent P
    Neurology; 2005 Sep; 65(5):701-6. PubMed ID: 16157902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurochemical changes in welders revealed by proton magnetic resonance spectroscopy.
    Chang Y; Woo ST; Lee JJ; Song HJ; Lee HJ; Yoo DS; Kim SH; Lee H; Kwon YJ; Ahn HJ; Ahn JH; Park SJ; Weon YC; Chung IS; Jeong KS; Kim Y
    Neurotoxicology; 2009 Nov; 30(6):950-7. PubMed ID: 19631686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Magnetic resonance imaging in late-onset ornithine transcarbamylase deficiency.
    Kurihara A; Takanashi Ji; Tomita M; Kobayashi K; Ogawa A; Kanazawa M; Yamamoto S; Kohno Y
    Brain Dev; 2003 Jan; 25(1):40-4. PubMed ID: 12536032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurochemical alterations of the brain in bipolar disorder and their implications for pathophysiology: a systematic review of the in vivo proton magnetic resonance spectroscopy findings.
    Yildiz-Yesiloglu A; Ankerst DP
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):969-95. PubMed ID: 16677749
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton magnetic resonance spectroscopy as a probe into the pathophysiology of autism spectrum disorders (ASD): a review.
    Baruth JM; Wall CA; Patterson MC; Port JD
    Autism Res; 2013 Apr; 6(2):119-33. PubMed ID: 23436782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered white and gray matter metabolism in CADASIL: a proton MR spectroscopy and 1H-MRSI study.
    Auer DP; Schirmer T; Heidenreich JO; Herzog J; Pütz B; Dichgans M
    Neurology; 2001 Mar; 56(5):635-42. PubMed ID: 11245716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes in Ornithine Transcarbamylase deficiency: a series of 90 patients.
    Brassier A; Gobin S; Arnoux JB; Valayannopoulos V; Habarou F; Kossorotoff M; Servais A; Barbier V; Dubois S; Touati G; Barouki R; Lesage F; Dupic L; Bonnefont JP; Ottolenghi C; De Lonlay P
    Orphanet J Rare Dis; 2015 May; 10():58. PubMed ID: 25958381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Lactobacillus acidophilus improve minimal hepatic encephalopathy? A neurometabolite study using magnetic resonance spectroscopy.
    Ziada DH; Soliman HH; El Yamany SA; Hamisa MF; Hasan AM
    Arab J Gastroenterol; 2013 Sep; 14(3):116-22. PubMed ID: 24206740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain N-acetylaspartate is elevated in Pelizaeus-Merzbacher disease with PLP1 duplication.
    Takanashi J; Inoue K; Tomita M; Kurihara A; Morita F; Ikehira H; Tanada S; Yoshitome E; Kohno Y
    Neurology; 2002 Jan; 58(2):237-41. PubMed ID: 11805250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proton magnetic resonance spectroscopy in school-aged autistic children.
    Vasconcelos MM; Brito AR; Domingues RC; da Cruz LC; Gasparetto EL; Werner J; Gonçalves JP
    J Neuroimaging; 2008 Jul; 18(3):288-95. PubMed ID: 18304036
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated Myo-Inositol, Choline, and Glutamate Levels in the Associative Striatum of Antipsychotic-Naive Patients With First-Episode Psychosis: A Proton Magnetic Resonance Spectroscopy Study With Implications for Glial Dysfunction.
    Plitman E; de la Fuente-Sandoval C; Reyes-Madrigal F; Chavez S; Gómez-Cruz G; León-Ortiz P; Graff-Guerrero A
    Schizophr Bull; 2016 Mar; 42(2):415-24. PubMed ID: 26320195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical characteristics of patients with ornithine transcarbamylase deficiency.
    Peng MZ; Li XZ; Mei HF; Sheng HY; Yin X; Jiang MY; Cai YN; Su L; Lin YT; Shao YX; Liu L
    Clin Biochem; 2020 Oct; 84():63-72. PubMed ID: 32569589
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.